UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 79

Sortiert nach

Expression of tumor-associated differentiation antigens, MUC1 glycoforms and CEA, in human thymic epithelial cells : Implications for self-tolerance and tumor therapy

Cancer research (Chicago, Ill.), 2007-04, Vol.67 (8), p.3919-3926

2007

Volltextzugriff (PDF)

The Effect of Vitamin C (Ascorbic Acid) in the Treatment of Patients with Cancer: A Systematic Review

Nutrients, 2019-04, Vol.11 (5), p.977

2019

Volltextzugriff (PDF)

A comprehensive overview of FCGR3A gene variability by full-length gene sequencing including the identification of V158F polymorphism

Scientific reports, 2018-10, Vol.8 (1), p.15983-11, Article 15983

2018

Volltextzugriff (PDF)

Cereblon loss and up-regulation of c-Myc are associated with lenalidomide resistance in multiple myeloma patients

Haematologica (Roma), 2018-08, Vol.103 (8), p.e368

2018

Volltextzugriff (PDF)

Tuning Natural Killer Cell Anti-multiple Myeloma Reactivity by Targeting Inhibitory Signaling via KIR and NKG2A

Frontiers in immunology, 2018-12, Vol.9, p.2848

2018

Volltextzugriff (PDF)

Rosuvastatin Enhances VSV-G Lentiviral Transduction of NK Cells via Upregulation of the Low-Density Lipoprotein Receptor

Molecular therapy. Methods & clinical development, 2020-06, Vol.17, p.634-646

2020

Volltextzugriff (PDF)

Ascorbic acid promotes proliferation of natural killer cell populations in culture systems applicable for natural killer cell therapy

Cytotherapy (Oxford, England), 2015-05, Vol.17 (5), p.613-620

2015

Volltextzugriff (PDF)

Medical students perceive better group learning processes when large classes are made to seem small

PloS one, 2014-04, Vol.9 (4), p.e93328-e93328

2014

Volltextzugriff (PDF)

NKG2A Expression Is Not per se Detrimental for the Anti-Multiple Myeloma Activity of Activated Natural Killer Cells in an In Vitro System Mimicking the Tumor Microenvironment

Frontiers in immunology, 2018-06, Vol.9, p.1415-1415

2018

Volltextzugriff (PDF)

Pathogen-Associated Molecular Patterns Induced Crosstalk between Dendritic Cells, T Helper Cells, and Natural Killer Helper Cells Can Improve Dendritic Cell Vaccination

Mediators of inflammation, 2016-01, Vol.2016, p.5740373-12

2016

Volltextzugriff (PDF)

The Next Step Toward Patient-Centeredness in Multidisciplinary Cancer Team Meetings: An Interview Study with Professionals

Journal of multidisciplinary healthcare, 2021-01, Vol.14, p.1311-1324

2021

Volltextzugriff (PDF)

Extended follow up of high-dose melphalan and autologous stem cell transplantation after vincristine, doxorubicin, dexamethasone induction in amyloid light chain amyloidosis of the prospective phase II HOVON-41 study by the Dutch-Belgian Co-operative Trial Group for Hematology Oncology

Haematologica (Roma), 2015-05, Vol.100 (5), p.677

2015

Volltextzugriff (PDF)

Phase I/II trial of weekly bortezomib with lenalidomide and dexamethasone in first relapse or primary refractory myeloma

Haematologica (Roma), 2016-04, Vol.101 (4), p.e149

2016

Volltextzugriff (PDF)

Hyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis

The New England journal of medicine, 1996-03, Vol.334 (12), p.759-762

1996

Volltextzugriff (PDF)

Klebsiella pneumoniae‐triggered DC recruit human NK cells in a CCR5‐dependent manner leading to increased CCL19‐responsiveness and activation of NK cells

European journal of immunology, 2010-11, Vol.40 (11), p.3138-3149

2010

Volltextzugriff (PDF)

Elimination of the chemotherapy resistant subpopulation of 4T1 mouse breast cancer by haploidentical NK cells cures the vast majority of mice

Breast cancer research and treatment, 2011-12, Vol.130 (3), p.773-781

2011

Volltextzugriff (PDF)

Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy

Journal of hematology and oncology, 2021-05, Vol.14 (1), p.73-73, Article 73

2021

Volltextzugriff (PDF)

Flow cytometry-based assay to evaluate human serum MUC1-Tn antibodies

Journal of immunological methods, 2011-02, Vol.365 (1-2), p.87-94

2011

Volltextzugriff (PDF)

OR35

Human immunology, 2014-10, Vol.75, p.31-31

2014

Volltextzugriff (PDF)

Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers

Arteriosclerosis, thrombosis, and vascular biology, 1998-03, Vol.18 (3), p.356

1998

Volltextzugriff (PDF)

Hypoxia induced impairment of NK cell cytotoxicity against multiple myeloma can be overcome by IL-2 activation of the NK cells

PloS one, 2013-05, Vol.8 (5), p.e64835

2013

Volltextzugriff (PDF)

53-OR: HLA class I and HLA-E influence susceptibility of multiple myeloma cells to elimination by NK cells

Human immunology, 2011-10, Vol.72, p.S192-S192

2011

Volltextzugriff (PDF)

Interfering with KIR and NKG2A immune checkpoint axes to unleash NK cell immunotherapy

Best practice & research. Clinical haematology, 2024-07, p.101568, Article 101568

2024

Volltextzugriff (PDF)

Inhibitory receptors for HLA class I as immune checkpoints for natural killer cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy

Cancer Immunology, Immunotherapy, 2023-04, Vol.72 (4), p.797-804

2023

Volltextzugriff (PDF)

1 – 25 von 79

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieBlood

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(68)

Publikationsform

Artikel
(79)

Sprache

Englisch
(79)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Expression of tumor-associated differentiation antigens, MUC1 glycoforms and CEA, in human thymic epithelial cells : Implications for self-tolerance and tumor therapy

Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma: Results of the Randomized Phase III HOVON-65/ GMMG-HD4 Trial

The Effect of Vitamin C (Ascorbic Acid) in the Treatment of Patients with Cancer: A Systematic Review

A comprehensive overview of FCGR3A gene variability by full-length gene sequencing including the identification of V158F polymorphism

Cereblon loss and up-regulation of c-Myc are associated with lenalidomide resistance in multiple myeloma patients

Tuning Natural Killer Cell Anti-multiple Myeloma Reactivity by Targeting Inhibitory Signaling via KIR and NKG2A

Rosuvastatin Enhances VSV-G Lentiviral Transduction of NK Cells via Upregulation of the Low-Density Lipoprotein Receptor

Ascorbic acid promotes proliferation of natural killer cell populations in culture systems applicable for natural killer cell therapy

Medical students perceive better group learning processes when large classes are made to seem small

NKG2A Expression Is Not per se Detrimental for the Anti-Multiple Myeloma Activity of Activated Natural Killer Cells in an In Vitro System Mimicking the Tumor Microenvironment

Pathogen-Associated Molecular Patterns Induced Crosstalk between Dendritic Cells, T Helper Cells, and Natural Killer Helper Cells Can Improve Dendritic Cell Vaccination

The Next Step Toward Patient-Centeredness in Multidisciplinary Cancer Team Meetings: An Interview Study with Professionals

Extended follow up of high-dose melphalan and autologous stem cell transplantation after vincristine, doxorubicin, dexamethasone induction in amyloid light chain amyloidosis of the prospective phase II HOVON-41 study by the Dutch-Belgian Co-operative Trial Group for Hematology Oncology

Phase I/II trial of weekly bortezomib with lenalidomide and dexamethasone in first relapse or primary refractory myeloma

Hyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis

Klebsiella pneumoniae‐triggered DC recruit human NK cells in a CCR5‐dependent manner leading to increased CCL19‐responsiveness and activation of NK cells

Elimination of the chemotherapy resistant subpopulation of 4T1 mouse breast cancer by haploidentical NK cells cures the vast majority of mice

Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy

Flow cytometry-based assay to evaluate human serum MUC1-Tn antibodies

OR35

Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers

Hypoxia induced impairment of NK cell cytotoxicity against multiple myeloma can be overcome by IL-2 activation of the NK cells

53-OR: HLA class I and HLA-E influence susceptibility of multiple myeloma cells to elimination by NK cells

Interfering with KIR and NKG2A immune checkpoint axes to unleash NK cell immunotherapy

Inhibitory receptors for HLA class I as immune checkpoints for natural killer cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy

Aktive Filter

Suchergebnisse filtern